Lilly invests further $5.3 bln in new Indiana site as obesity drug demand soars

Eli Lilly (LLY.N) said on Friday it has invested another $5.3 billion in its new Lebanon, Indiana manufacturing plant, more than doubling its previous investment, as it scrambles to meet soaring demand for its weight-loss and diabetes drugs.